Abstract
Although DNA methylation (DNAm) of multiple CpG sites measured in peripheral blood have been associated with PTSD status, these do not individually discriminate those with or without PTSD. Our goal is to develop and validate a DNA methylation risk score (MRS) from DNAm data and a limited set of phenotypes that collectively predict PTSD.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
